Skip to content

The Role of CircDENND4C in Epithelial Ovarian Cancer

The Role of CircDENND4C in Epithelial Ovarian Cancer

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06617585
Enrollment
30
Registered
2024-09-27
Start date
2024-12-01
Completion date
2028-10-01
Last updated
2024-09-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian Cancer

Brief summary

circular RNAs (circRNAs), a newly discovered type of endogenous noncoding RNAs \[8\], are involved in the regulation of various biological functions. They act by sponging off certain microRNAs (miRNAs) and play a role in the pathogenesis of many diseases, including cancers \[9-11\]. In addition, circRNAs are not com- monly degraded by RNA enzymes present in body flu- ids \[8\], and most of them possess expression specificity at the tissue, cell, and developmental stage level \[12,13\]. Thus, they can be ideal clinica

Detailed description

epithelial OC (EOC), the most common form of OC, accounts for 90% of all OC cases \[2\]. EOC has the highest mortality among all gynecologic tumors and poses a serious threat to women's life \[3\].herefore, early clinical diagnosis is crucial. Commonly used laboratory indicators for OC diagnosis

Interventions

None listed

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

\- patients at South Egypt Cancer institute and Recently diagnosed ovarian cancer patients 2. Patients not went to surgery.

Exclusion criteria

* . Patients receive any anti-cancer therapy. 2. Patients diagnosed with other concomitante cancer or chronic disease

Design outcomes

Primary

MeasureTime frameDescription
role of circDENND4c in the diagnosis of ovarian cancerbaselineby quality real time PCR we use the circDENND4c as a tumour marker for ovarian cancer

Contacts

Primary ContactMarwa MamDouh Mohamed
marwaamamdouh26@gmail.com20+1153538300

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026